Thomas LaVoy - IsoRay Independent Director

ISRDelisted Stock  USD 0.38  0.01  2.70%   

Director

Mr. Thomas C. LaVoy is Chairman of the Board, Chief Executive Officer of the Company, since February 15, 2016. He was appointed Chairman of the IsoRay Board effective January 7, 2016 and took office as Chief Executive Officer of the Company on February 15, 2016. Mr. LaVoy served as Deputy Chief Operations Officer and President of Corporationrationrate Services of Veolia Transportation on Demand, the parent company of SuperShuttle International Inc. and its subsidiaries, from January 2014 to February 2016. He concurrently served as Chief Financial Officer of SuperShuttle International, Inc. and its subsidiaries from July 1997 and as Secretary from March 1998, resigning from both positions in February 2016. He has also served as a director of Alanco Technologies, Inc. since 1998 and served on its audit committee from 2012 to 2015. From September 1987 to February 1997, Mr. LaVoy served as Chief Financial Officer of NASDAQlisted Photocomm, Inc. Mr. LaVoy was a Certified Public Accountant with the firm of KPMG Peat Marwick from 1980 to 1983 since 2016.
Age 56
Tenure 8 years
Phone509 375 1202
Webhttps://isoray.com
LaVoy has a BS degree in Accounting from St. Cloud University, Minnesota, and is a Certified Public Accountant in the State of Minnesota.

IsoRay Management Efficiency

The company has Return on Asset of (0.1085) % which means that on every $100 spent on assets, it lost $0.1085. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.1741) %, meaning that it generated no profit with money invested by stockholders. IsoRay's management efficiency ratios could be used to measure how well IsoRay manages its routine affairs as well as how well it operates its assets and liabilities.

Similar Executives

Showing other executives

DIRECTOR Age

Michael DominguezCDW Corp
45
William HultTradeweb Markets
54
Glenn CreamerCDW Corp
53
Alain MartinetMarfrig Global Foods
66
Barry AllenCDW Corp
69
Vinayak HegdeLifevantage
N/A
Rodrigo MarcalMarfrig Global Foods
N/A
Diego ApalateguiBBB Foods
47
Antonio MacielMarfrig Global Foods
N/A
Robin SelatiCDW Corp
49
David TooleLifevantage
60
Marcia SantosMarfrig Global Foods
N/A
Joseph SwedishCDW Corp
66
Donna ZarconeCDW Corp
60
Ernesto LozardoMarfrig Global Foods
N/A
Mike HusseyTradeweb Markets
46
Peter RedfernTradeweb Markets
40
Fabio VasconcellosMarfrig Global Foods
N/A
Jose MironMarfrig Global Foods
52
Robert RowleyTradeweb Markets
66
Benjamin ChereskinCDW Corp
59
Isoray, Inc., together with its subsidiaries, develops, manufactures, sells, and markets isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. Isoray, Inc. was founded in 1998 and is based in Richland, Washington. Isoray operates under Medical Devices classification in the United States and is traded on AMEX Exchange. It employs 66 people. IsoRay Inc (ISR) is traded on NYSE MKT Exchange in USA and employs 66 people.

Management Performance

IsoRay Inc Leadership Team

Elected by the shareholders, the IsoRay's board of directors comprises two types of representatives: IsoRay inside directors who are chosen from within the company, and outside directors, selected externally and held independent of IsoRay. The board's role is to monitor IsoRay's management team and ensure that shareholders' interests are well served. IsoRay's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, IsoRay's outside directors are responsible for providing unbiased perspectives on the board's policies.
Mark Austin, Principal Accounting Officer, Co-Principal Financial Officer, Controller
Alan Hoffmann, Independent Director
Lisa Lauer, Vice President - Business Development
Lori Woods, Interim Chief Executive Officer, Director
Michael McCormick, Independent Chairman of the Board
Jonathan Hunt, Chief Financial Officer, Co-Principal Financial Officer
Thomas LaVoy, Independent Director
William Cavanagh, Vice President - Research and Development
Lori HolmesWoods, CEO Director
Michael Krachon, Vice President, Director of Sales and Marketing
Jennifer Streeter, Interim Chief Operating Officer, Vice President of Human Resources
Mark CPA, Controller, Fin
William III, Chief Officer
Philip Vitale, Independent Director
Krista Cline, Senior Director of Operations, Corporate Secretary
Matthew Branson, Principal Financial Officer
Patricia Mills, NE Area Sales Director
Brien Ragle, CFO

IsoRay Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is IsoRay a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards IsoRay in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, IsoRay's short interest history, or implied volatility extrapolated from IsoRay options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.
You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Other Consideration for investing in IsoRay Stock

If you are still planning to invest in IsoRay Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the IsoRay's history and understand the potential risks before investing.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities